By Pietro Lombardi 
 

Roche Holding AG (RO.EB) is extending the offering period for its planned acquisition of Philadelphia biotechnology company Spark Therapeutics Inc. (ONCE), it said Tuesday.

The offering period has been extended to June 14, it said, after the companies decided to refile around May 23 their respective premerger notification and report forms under the Hart-Scott-Rodino Act.

The decision will provide the government with additional time to complete its current review, the Swiss pharmaceutical company said.

"The regulatory review of the transaction is ongoing, and the parties are actively working with the government to facilitate that process," it added.

 

Write to Pietro Lombardi at pietro.lombardi@dowjones.com

 

(END) Dow Jones Newswires

May 14, 2019 02:03 ET (06:03 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Aug 2020 to Sep 2020 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Sep 2019 to Sep 2020 Click Here for more Roche (QX) Charts.